| VCIGX | VVIAX | VCIGX / VVIAX | |
| Total Expense Ratio | 0.67 | 0.05 | 1,340% |
| Annual Report Gross Expense Ratio | 0.82 | 0.05 | 1,640% |
| Fund Existence | 25 years | 25 years | - |
| Gain YTD | 8.672 | 9.352 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 507M | 208B | 0% |
| Annual Yield % from dividends | 2.03 | 2.09 | 97% |
| Returns for 1 year | 5.30 | 5.07 | 105% |
| Returns for 3 years | 11.89 | 30.25 | 39% |
| Returns for 5 years | 33.04 | 62.97 | 52% |
| Returns for 10 years | 25.62 | 123.10 | 21% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSMJ | 31.48 | 0.03 | +0.10% |
| Pacer Swan SOS Moderate (July) ETF | |||
| RYLG | 22.11 | -0.01 | -0.06% |
| Global X Russell 2000 Cov Cl & Gr ETF | |||
| XSOE | 38.08 | -0.11 | -0.29% |
| WisdomTree EmMkts ex-Stt-Ownd EntrprsETF | |||
| DJD | 56.11 | -0.17 | -0.30% |
| Invesco Dow Jones Industrial Avg Div ETF | |||
| THNR | 25.13 | -0.08 | -0.33% |
| Amplify Weight Loss Drug & Treatment ETF | |||